Adverse Event Risk Up for >90 Days Versus >30 Days of Corticosteroids for Eczema
Authors suggest limiting duration of oral corticosteroid treatment to 90 days or less to reduce risk of adverse effects
Long-Term Sulfonylurea Use Tied to Impaired Awareness of Hypoglycemia
Odds are lessened with regular diabetes-related medical care
Digoxin, Beta-Blockers Have Equivalent Effects on Heart Rate in A-Fib
Wearable device data could predict New York Heart Association functional class similarly to clinical measures and six-minute walk test
Long COVID Incidence Declined Over Course of Pandemic
However, authors say, risk remains substantial even among vaccinated persons during the omicron era
2011 to 2023 Saw Increase in New GLP-1 Receptor Agonist Prescriptions
Increase seen in proportion of users without type 2 diabetes, with BMI ≥30, or with BMI of 27 to 30 and obesity-linked comorbidity
Study Looks at Co-Use of CYP2D6-Metabolizing Opioids, Antidepressants in Seniors
CYP2D6-inhibiting antidepressants linked to worse outcomes than CYP2D6-neutral antidepressants when used with CYP2D6-metabolizing opioids
Neuromuscular Training Cuts Onset of Chemo-Induced Peripheral Neuropathy
Incidence of CIPN significantly lower for patients undergoing sensorimotor training, whole-body vibration training
COVID-19 Infection, Vaccination Not Linked to Congenital Anomalies
In study of infants from Sweden, Denmark, and Norway, no link seen for infection or vaccination in the first trimester with congenital anomalies
Efanesoctocog Alfa Prophylaxis Beneficial for Children With Hemophilia A
Authors note high sustained factor VIII activity and protection against bleeding episodes, including bleeding into joints
Micronutrient Supplementation Slows Geographic Atrophy Progression
In eyes with noncentral GA, proximity-based progression toward central macula was slower with randomization to antioxidants
